We are live on ! Find out more
HR

Howe & Rusling Portfolio holdings

AUM $1.53B
1-Year Est. Return 21.45%
This Fund
S&P 500
This Quarter Est. Return
+5.63%
1 Year Est. Return
+21.45%
3 Year Est. Return
+66.11%
5 Year Est. Return
+83.74%
10 Year Est. Return
+259.21%
AUM
$894M
AUM Growth
+$54.4M
Cap. Flow
+$11.9M
Cap. Flow %
1.33%
Top 10 Hldgs %
28.23%
Holding
350
New
47
Increased
126
Reduced
110
Closed
18

Top Buys

Rank Stock Value
1
APH icon
Amphenol
APH
+$6.69M
2
ACN icon
Accenture
ACN
+$4.77M
3
G icon
Genpact
G
+$3.22M
4
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$3.04M
5
KLAC icon
KLA
KLAC
+$2.23M

Top Sells

Rank Stock Value
1
OKE icon
Oneok
OKE
+$4.03M
2
JNJ icon
Johnson & Johnson
JNJ
+$3.23M
3
UNH icon
UnitedHealth
UNH
+$2.21M
4
VTWO icon
Vanguard Russell 2000 ETF
VTWO
+$1.77M
5
AZN icon
AstraZeneca
AZN
+$1.53M

Sector Composition

Rank Sector Weight
1 Technology 15.86%
2 Healthcare 11.58%
3 Financials 10.42%
4 Consumer Staples 8.55%
5 Industrials 6.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDLZ icon
51
Mondelez International
MDLZ
$79.9B
$6.34M 0.71%
86,980
+144
+0.2% +$10.6K
COR icon
52
Cencora
COR
$61.7B
$6.04M 0.68%
31,409
+166
+0.5% +$28.7K
MA icon
53
Mastercard
MA
$500B
$5.83M 0.65%
14,813
+42
+0.3% +$15.8K
SCHW
54
Charles Schwab
SCHW
$188B
$5.79M 0.65%
102,218
-1,141
-1% -$59.8K
EA icon
55
Electronic Arts
EA
$52.9B
$5.79M 0.65%
44,631
+1,069
+2% +$135K
IJR icon
56
iShares Core S&P Small-Cap ETF
IJR
$112B
$5.75M 0.64%
57,683
+1,760
+3% +$168K
HON icon
57
Honeywell
HON
$78.6B
$5.67M 0.63%
28,981
+388
+1% +$72.1K
BMY icon
58
Bristol-Myers Squibb
BMY
$130B
$5.52M 0.62%
86,287
-20
-0% -$1.34K
MO icon
59
Altria Group
MO
$114B
$5.44M 0.61%
119,988
+2,322
+2% +$105K
ACN icon
60
Accenture
ACN
$104B
$5.07M 0.57%
+16,424
New +$4.77M
USB icon
61
US Bancorp
USB
$100B
$5.01M 0.56%
151,611
-3,399
-2% -$110K
MCK icon
62
McKesson
MCK
$103B
$4.65M 0.52%
10,876
-2,827
-21% -$1.09M
COST icon
63
Costco
COST
$418B
$4.56M 0.51%
8,469
-44
-0.5% -$22.3K
BKNG icon
64
Booking.com
BKNG
$160B
$4.34M 0.49%
40,225
-125
-0.3% -$13.2K
BAX icon
65
Baxter International
BAX
$14.1B
$4.34M 0.49%
95,330
+5,044
+6% +$220K
FISV
66
Fiserv Inc
FISV
$28.9B
$3.67M 0.41%
29,122
-511
-2% -$60.2K
INTU icon
67
Intuit
INTU
$89.7B
$3.52M 0.39%
7,686
+267
+4% +$117K
NEM icon
68
Newmont
NEM
$110B
$3.26M 0.37%
76,484
+712
+0.9% +$32.3K
EW icon
69
Edwards Lifesciences
EW
$51.2B
$3.17M 0.35%
33,555
+645
+2% +$56.1K
BMRN icon
70
BioMarin Pharmaceuticals
BMRN
$11.6B
$3.09M 0.35%
35,613
-74
-0.2% -$6.96K
PINS icon
71
Pinterest
PINS
$13.1B
$3.08M 0.34%
112,563
+22,434
+25% +$559K
G icon
72
Genpact
G
$5.98B
$3.01M 0.34%
+80,036
New +$3.22M
PANW icon
73
Palo Alto Networks
PANW
$296B
$2.93M 0.33%
22,948
+112
+0.5% +$11.7K
VRTX icon
74
Vertex Pharmaceuticals
VRTX
$123B
$2.82M 0.32%
8,011
-339
-4% -$114K
LHX icon
75
L3Harris
LHX
$53.3B
$2.8M 0.31%
14,313
+60
+0.4% +$11.5K

Similar funds

Howe & Rusling's Q2 2023 Portfolio in Review

As of Q2 2023, Howe & Rusling held 350 positions worth $894M, up 6.5% from $839M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Howe & Rusling's Q2 2023 filing shows 47 new, 126 increased, 110 reduced and 18 closed positions. Its largest new stake was Amphenol: 172,144 shares worth $7.31M. The largest sale was Oneok, an estimated $4.03M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 13% a quarter earlier, followed by Healthcare and Financials.

  • Howe & Rusling's largest Q2 2023 buy was Amphenol: 172,144 shares worth $7.31M.
  • Howe & Rusling added most to Vanguard Morningstar Total Stock Market ETF in Q2 2023, an estimated $3.04M increase.
  • Howe & Rusling's biggest Q2 2023 reduction was Oneok, cutting an estimated $4.03M.
  • Howe & Rusling fully exited Charter Communications in Q2 2023, selling an estimated $494K.
  • Howe & Rusling's ten largest holdings make up 28% of its $894M portfolio in Q2 2023.
  • Howe & Rusling opened 47 new positions and closed 18 in Q2 2023.
  • Howe & Rusling's portfolio value rose 6.5% quarter-over-quarter to $894M.

Based on Howe & Rusling's 13F filing for Q2 2023, filed 14 Aug 2023.